{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T10:21:42Z","timestamp":1770978102503,"version":"3.50.1"},"reference-count":26,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,4,10]],"date-time":"2015-04-10T00:00:00Z","timestamp":1428624000000},"content-version":"vor","delay-in-days":3266,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2006,5]]},"DOI":"10.1016\/j.bbmt.2005.12.032","type":"journal-article","created":{"date-parts":[[2006,4,24]],"date-time":"2006-04-24T23:42:40Z","timestamp":1145922160000},"page":"552-559","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":98,"title":["Voriconazole and Sirolimus Coadministration after Allogeneic Hematopoietic Stem Cell Transplantation"],"prefix":"10.1016","volume":"12","author":[{"given":"Francisco M.","family":"Marty","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Colleen M.","family":"Lowry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Corey S.","family":"Cutler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bonnie J.","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"Fiumara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lindsey R.","family":"Baden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph H.","family":"Antin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2005.12.032_bib1","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/sj.bmt.1704604","article-title":"Sirolimus for GVHD prophylaxis in allogeneic stem cell transplantation","volume":"34","author":"Cutler","year":"2004","journal-title":"Bone Marrow Transplant"},{"issue":"3 suppl","key":"10.1016\/j.bbmt.2005.12.032_bib2","doi-asserted-by":"crossref","first-page":"201S","DOI":"10.1016\/S0041-1345(03)00231-8","article-title":"Rapamycin in combination with cyclosporine or tacrolimus in liver, pancreas, and kidney transplantation","volume":"35","author":"MacDonald","year":"2003","journal-title":"Transplant Proc"},{"key":"10.1016\/j.bbmt.2005.12.032_bib3","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1182\/blood-2003-02-0489","article-title":"Sirolimus, tacrolimus, and low-dose methotrexate for graft-versus-host disease prophylaxis in mismatched related donor or unrelated donor transplantation","volume":"102","author":"Antin","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2005.12.032_bib4","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.bbmt.2003.12.305","article-title":"Sirolimus and tacrolimus without methotrexate as graft-versus-host disease prophylaxis after matched related donor peripheral blood stem cell transplantation","volume":"10","author":"Cutler","year":"2004","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2005.12.032_bib5","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1182\/blood-2003-01-0267","article-title":"Infliximab use in patients with severe graft-versus-host disease and other emerging risk factors of non-Candida invasive fungal infections in allogeneic hematopoietic stem cell transplant recipients","volume":"102","author":"Marty","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2005.12.032_bib6","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1128\/CMR.18.1.44-69.2005","article-title":"Aspergillus infections in transplant recipients","volume":"18","author":"Singh","year":"2005","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.bbmt.2005.12.032_bib7","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1086\/339202","article-title":"Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients","volume":"34","author":"Marr","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bbmt.2005.12.032_bib8","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1056\/NEJMoa020191","article-title":"Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis","volume":"347","author":"Herbrecht","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2005.12.032_bib9","series-title":"NDA 21-266 and 21-267, Vfend\u2122\u20dd (voriconazole)","year":"2002"},{"key":"10.1016\/j.bbmt.2005.12.032_bib10","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1086\/374557","article-title":"Voriconazole treatment for less-common, emerging, or refractory fungal infections","volume":"36","author":"Perfect","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bbmt.2005.12.032_bib11","series-title":"Product Information","year":"2005"},{"key":"10.1016\/j.bbmt.2005.12.032_bib12","series-title":"12th European Congress of Clinical Microbiology and Infectious Diseases","article-title":"Effect of voriconazole on the pharmacokinetics of sirolimus (poster)","author":"Abel","year":"2002"},{"key":"10.1016\/j.bbmt.2005.12.032_bib13","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1086\/323335","article-title":"Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants","volume":"34","author":"Ascioglu","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bbmt.2005.12.032_bib14","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.bbmt.2005.06.001","article-title":"Blood and marrow transplant clinical trials network toxicity committee consensus summary","volume":"11","author":"Ho","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2005.12.032_bib15","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.bbmt.2005.04.007","article-title":"Sirolimus and thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation","volume":"11","author":"Cutler","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2005.12.032_bib16","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1016\/j.transproceed.2004.09.043","article-title":"Combined use of sirolimus and voriconazole in renal transplantation","volume":"36","author":"Mathis","year":"2004","journal-title":"Transplant Proc"},{"key":"10.1016\/j.bbmt.2005.12.032_bib17","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1111\/j.1399-0012.2005.00356.x","article-title":"Sirolimus-associated interstitial pneumonitis in solid organ transplant recipients","volume":"19","author":"Garrean","year":"2005","journal-title":"Clin Transplant"},{"key":"10.1016\/j.bbmt.2005.12.032_bib18","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1097\/00007890-200109150-00008","article-title":"Characteristics of sirolimus-associated interstitial pneumonitis in renal transplant patients","volume":"72","author":"Morelon","year":"2001","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2005.12.032_bib19","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJM200007203430317","article-title":"Interstitial pneumonitis associated with sirolimus therapy in renal-transplant recipients","volume":"343","author":"Morelon","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2005.12.032_bib20","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1056\/NEJM200012143432417","article-title":"Interstitial pneumonitis associated with sirolimus therapy in renal-transplant recipients","volume":"343","author":"Singer","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2005.12.032_bib21","doi-asserted-by":"crossref","first-page":"541","DOI":"10.4065\/79.4.541","article-title":"Sirolimus-associated diffuse alveolar hemorrhage","volume":"79","author":"Vlahakis","year":"2004","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.bbmt.2005.12.032_bib22","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1093\/ndt\/gfh593","article-title":"Interaction between voriconazole and tacrolimus in a kidney-transplanted patient","volume":"20","author":"Tintillier","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.bbmt.2005.12.032_bib23","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1128\/AAC.46.9.3091-3093.2002","article-title":"Voriconazole inhibition of the metabolism of tacrolimus in a liver transplant recipient and in human liver microsomes","volume":"46","author":"Venkataramanan","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bbmt.2005.12.032_bib24","series-title":"Drug Interactions in Infectious Diseases","author":"Piscitelli","year":"2005"},{"key":"10.1016\/j.bbmt.2005.12.032_bib25","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1124\/jpet.102.037549","article-title":"Interaction of cytochrome P450 3A inhibitors with P-glycoprotein","volume":"303","author":"Yasuda","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bbmt.2005.12.032_bib26","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1124\/jpet.301.1.174","article-title":"Identification of a novel route of extraction of sirolimus in human small intestine","volume":"301","author":"Paine","year":"2002","journal-title":"J Pharmacol Exp Ther"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S108387910501414X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S108387910501414X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:26:17Z","timestamp":1761056777000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S108387910501414X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,5]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2006,5]]}},"alternative-id":["S108387910501414X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2005.12.032","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2006,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Voriconazole and Sirolimus Coadministration after Allogeneic Hematopoietic Stem Cell Transplantation","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2005.12.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}